Characterization of a murine mixed neuron-glia model and cellular responses to regulatory T cell-derived factors by Dittmer, Marie et al.
Characterization of a murine mixed neuron-glia model and cellular
responses to regulatory T cell-derived factors
Dittmer, M., Young, A., O'Hagan, T., Eleftheriadis, G., Bankhead, P., Dombrowski, Y., ... Fitzgerald, D. C.
(2018). Characterization of a murine mixed neuron-glia model and cellular responses to regulatory T cell-derived
factors. Molecular Brain, 11(1), 1-25. DOI: 10.1186/s13041-018-0367-6
Published in:
Molecular Brain
Document Version:
Publisher's PDF, also known as Version of record
Queen's University Belfast - Research Portal:
Link to publication record in Queen's University Belfast Research Portal
Publisher rights
Copyright 2018 the authors.
This is an open access article published under a Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/),
which permits unrestricted use, distribution and reproduction in any medium, provided the author and source are cited.
General rights
Copyright for the publications made accessible via the Queen's University Belfast Research Portal is retained by the author(s) and / or other
copyright owners and it is a condition of accessing these publications that users recognise and abide by the legal requirements associated
with these rights.
Take down policy
The Research Portal is Queen's institutional repository that provides access to Queen's research output. Every effort has been made to
ensure that content in the Research Portal does not infringe any person's rights, or applicable UK laws. If you discover content in the
Research Portal that you believe breaches copyright or violates any law, please contact openaccess@qub.ac.uk.
Download date:06. Aug. 2018
SHORT REPORT Open Access
Characterization of a murine mixed neuron-
glia model and cellular responses to
regulatory T cell-derived factors
Marie Dittmer1, Andrew Young1, Thomas O’Hagan1, George Eleftheriadis1, Peter Bankhead2, Yvonne Dombrowski1,
Reinhold J. Medina1 and Denise C. Fitzgerald1*
Abstract: One of the unmet clinical needs in demyelinating diseases such as Multiple Sclerosis (MS) is to provide
therapies that actively enhance the process of myelin regeneration (remyelination) in the central nervous system
(CNS). Oligodendrocytes, the myelinating cells of the CNS, play a central role in remyelination and originate from
oligodendrocyte progenitor cells (OPCs). We recently showed that depletion of regulatory T cells (Treg) impairs
remyelination in vivo, and that Treg-secreted factors directly enhance oligodendrocyte differentiation. Here we aim
to further characterize the dynamics of Treg-enhanced oligodendrocyte differentiation as well as elucidate the
cellular components of a murine mixed neuron-glia model.
Murine mixed neuron-glia cultures were generated from P2–7 C57BL/6 mice and characterized for percentage
of neuronal and glial cell populations prior to treatment at 7 days in vitro (div) as well as after treatment with
Treg-conditioned media at multiple timepoints up to 12 div.
Mixed neuron-glia cultures consisted of approximately 30% oligodendroglial lineage cells, 20% neurons and 10%
microglia. Furthermore, a full layer of astrocytes, that could not be quantified, was present. Treatment with
Treg-conditioned media enhanced the proportion of MBP+ oligodendrocytes and decreased the proportion of
PDGFRα+ OPCs, but did not affect OPC proliferation or survival. Treg-enhanced oligodendrocyte differentiation
was not caused by Treg polarizing factors, was dependent on the number of activation cycles Treg underwent
and was robustly achieved by using 5% conditioned media.
These studies provide in-depth characterization of a murine mixed neuron-glia model as well as further insights
into the dynamics of Treg-enhanced oligodendrocyte differentiation.
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Introduction
Multiple Sclerosis is one of a number of demyelinating
diseases of the central nervous system (CNS) yet there are
still no therapies that actively enhance the process of mye-
lin regeneration (remyelination). Uncovering the mecha-
nisms that govern remyelination and developing novel
remyelinating treatments could prove highly beneficial to
patients’ quality of life [1, 2]. For efficient central nervous
system remyelination to occur, oligodendrocyte progenitor
cells (OPCs) have to successfully migrate, survive, prolifer-
ate, differentiate, mature and wrap myelin sheath around
axons. While one study showed that OPCs of sufficient
numbers were present in about 80% of chronic demyelin-
ating lesions of early MS patients [3], another study re-
ported lesions with insufficient OPC numbers, indicating
OPC migration or proliferation as limiting factors in im-
paired remyelination [4]. However, enhanced OPC prolif-
eration and therefore available OPC numbers in lesions
does not appear to influence remyelination in a model of
lysolecithin-induced demyelination [5]. Therefore, a key
bottle-neck in remyelination appears to be oligodendro-
cyte differentiation and subsequent remyelination [3, 6, 7].
Currently there are no therapies to enhance oligodendro-
cyte differentiation, highlighting the need for appropriate,
well-characterized and efficient models to uncover and
develop novel treatments.
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A wide variety of experimental approaches have been
employed to study CNS (re)myelination. These approaches
include toxin-, viral- and immune-mediated in vivo models
of demyelinating disease, which are useful for studying the
complexity of de- and remyelination in vivo. However, to
study the cellular mechanisms governing these processes,
simpler models that permit more specific investigations at
cellular and molecular levels are necessary. Ex vivo brain
slice models can be used to study developmental myelin-
ation as well as demyelination and subsequent remyelina-
tion [8]. These models mirror the complexity and relative
cytoarchitecture of CNS tissues and due to a lack of
connection to the circulation, specific neural tissue re-
sponses can be studied without the influence of infiltrating
leukocytes. Finally, there are in vitro models that facilitate
the investigation of molecular and cellular mechanisms
underlying regeneration, such as the mixed glia model
that comprises cell types commonly found in the CNS but
not in typical functional architecture. In vitro models are
therefore valuable tools to study molecular mechanisms
and cell-specific effects. While mixed glia models are
commonly used, surprisingly little is published regarding
model characterization and even the name mixed glial cul-
ture can be considered a misnomer, as despite this name,
these cultures generally also contain other CNS-resident
cell types including neurons. Therefore, we sought to
provide an in-depth characterization of a murine mixed
neuron-glia in vitro model.
Recently, a growing body of research into the regen-
erative properties of regulatory T cells (Treg) in multiple
tissues including the lung, skin, spinal cord, muscle and
myocardium has emerged [9–15]. We showed for the
first time that murine Treg play a crucial role in myelin
generation and regeneration and can secrete factors
capable of directly enhancing oligodendrocyte differenti-
ation [16]. The Karimi-Abdolrezaee group showed that
Neuregulin-1 promotes remyelination in lysolecithin-
induced demyelination and they found a corresponding
increase of Treg in lesions of Neuregulin-1 treated animals
14 days post-lesioning [17]. In this study, we sought to
characterize a murine mixed neuron-glia model through
an investigative study of Treg influence on oligodendro-
cyte development.
The reductionist murine mixed neuron-glia model is a
useful tool to study basic immune cell responses in the
context of CNS cells. While devoid of peripherally-derived
infiltrating leukocytes, this model strikes a balance be-
tween the tissue complexity of ex vivo brain slice models
and pure OPC models, which completely lack the diversity
of CNS cells. Therefore, the murine mixed neuron-glia
model is ideal to study fundamental cellular processes
underlying neuro-immune interactions in the CNS. In this
study, we provide in-depth characterization of a murine
mixed neuron-glia model as well as detailed methods and
characterization of experimental conditions, including
media type, different concentrations and timecourses that
facilitate Treg-enhanced oligodendrocyte differentiation.
These studies are critical to understand the nuances of
Treg-mediated regulation of oligodendrocyte development.
This study can therefore aid the design of future studies in-
vestigating the effects of other (immune) cell subsets on
CNS cell populations.
Materials and methods
Animals
Mice were housed under standard laboratory conditions
(12/12 h light/dark cycle with a room temperature of
21 °C, humidity of 50% and water and food available ad
libitum). C57BL/6 mice were bred in-house or bought
from Charles River Laboratories and maintained in-house.
PLP-eGFP mice were a kind gift from Prof. Wendy
Macklin, Cleveland Clinic Foundation [18] and main-
tained in-house. Male and female C57BL/6 mice aged 2
to 9 postnatal days were used for mixed glial and pure
OPC cultures. Spleens from either all male or all female
C57BL/6 mice aged 6 to 12 weeks were used for T cell
cultures. All animal maintenance and experiments were
in compliance with the UK Home Office and approved
by the Queen’s University Belfast Animal Welfare and
Ethical Review Body (AWERB).
T cell culture, polarization and conditioned-media
generation
Spleens from C57BL/6 mice aged 6–12 weeks were ex-
tracted, passed through a 70 μm strainer and washed
with Phosphate Buffered Saline (PBS). Total or naïve
(CD62L+CD44−) CD4+ T cells were purified using the
EasySep Mouse CD4+ T cell isolation kit (Stemcell
Technologies Inc.) as per manufacturer’s instructions. In
general, for total CD4+ T cell isolation, splenocytes were
counted and resuspended to 1 × 108 cells/ml in purification
buffer containing 2% Foetal Bovine Serum (FBS) and 1 mM
EDTA in PBS. Next, normal rat serum (50 μl/ml) as well as
EasySep mouse CD4+ T cell isolation cocktail (50 μl/ml)
were added, mixed and incubated for 10 min at room
temperature (RT). Afterwards, EasySep Streptavidin
RapidSpheres (75 μl/ml) were added, mixed and incubated
for 2.5 min at RT. The suspension was brought up to a
total volume of 2.5 ml by adding purification buffer and the
tubes containing the suspension were placed into the
EasySep magnet for a further 2.5 min at RT. The purified
CD4+ cells were transferred into a new sterile tube. Purity
was assessed via flow cytometry and samples only further
used if purity was above 90%. At this point CD4+ T cells
were counted, resuspended in RPMI media (Invitrogen,
10% FBS, 1% sodium pyruvate, 1% HEPES, 1% non-
essential amino acids, 1% Penicillin/Streptomycin, 1%
L-Glutamine, 50 nM β-Mercaptoethanol) and plated at
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a density of 1 × 106 cells/ml in 1 ml volume per well of
a tissue culture-treated 24-well plate. CD4+ T cells were
activated through the addition of anti-CD3 (1 μg/ml,
clone 145-2C11, eBioscience) and anti-CD28 (1 μg/ml,
clone 37.5, eBioscience). Treg were polarized in vitro
through addition of murine IL-2 (10 or 20 ng/ml,
eBioscience), human TGF-β (2 or 4 ng/ml, eBioscience)
and anti-IFN-γ (10 μg/ml, BioXCell). Conditioned
media from these cultures were harvested after 3 days
and stored at − 80 °C. T cells were washed, counted and
polarization efficiency was assessed via flow cytometry
and samples only used in further experiments if Treg
polarization efficiency was above 80% as determined by
FoxP3 expression. Cells were replated at 1 × 106 cells/ml
in 1 ml volume per well of a 24-well plate in different
media (brain slice media (BSM) (MEM, 25% EBSS, 25%
heat-inactivated horse serum, 1% Penicillin/Streptomycin,
1% GlutaMAX, 0.65% D-glucose) or X-VIVO™ 15 (Lonza))
and again activated and polarized as before. Conditioned
media were harvested on the third day of the first, second
or third activation, spun down at 300 g for 5 min and
stored at − 80 °C. Polarization efficiency was checked after
each activation and samples only further used if Treg
polarization efficiency was above 80% as determined by
FoxP3 expression.
Flow cytometry
For flow cytometric analysis up to 1 × 106 cells per tube
were stained with surface antibodies at 1:1000 (CD45
(clone 104, eBioscience), CD3 (clone 17A2, eBioscience),
CD4 (clone GK1.5, eBioscience)) for 20 min at RT. Cells
were then fixed with 100 μl Fix&Perm Reagent A
(Invitrogen) for 15 min at RT and then stained with 1 μl
of intracellular antibodies (FoxP3 (clone FJK-16 s,
eBioscience)) in 100 μl Fix&Perm Reagent B (Invitrogen)
overnight at 4 °C. Fixed and permeabilized unstained
cells were used as a negative control, single color surface
stained cells or UltraComp beads (eBioscience) were used
for compensation and Fluorescence Minus One (FMO),
meaning cells that were identically stained as samples, but
were lacking one staining antibody at a time, were used to
control for multiple fluorochrome staining particularly for
intracellular targets. Cells and controls were analyzed
using a BD FACS Canto II cytometer and data were subse-
quently analyzed using FlowJo software (Treestar Inc.).
Mixed neuron-glia cultures
Mixed neuron-glia cells were generated from P2–7
C57BL/6 mouse pups according to the protocol of the
Neural Tissue Dissociation Kit (P) (Miltenyi Biotec). In
general, brains were dissected, cerebellum, olfactory bulbs
and meninges were removed and tissue was cut into small
pieces. Up to 2.5 brains per 15 ml falcon tube were papain
enzyme digested with enzyme mix 1, consisting of 50 μl
enzyme P and 1900 μl buffer X. The enzyme mix was in-
cubated with the dissociated tissue for 15 min at 37 °C on
a rotator. After addition of enzyme mix 2, consisting of
10 μl enzyme A and 20 μl of buffer Y, tissues were very
slowly dissociated mechanically using pasteur as well as
P1000 pipettes interspaced with two more 10 min incuba-
tions on a rotator at 37 °C. The suspension was then fil-
tered through a 40 μm strainer and cells pelleted at RT for
10 min at 300 rcf prior to resuspension in complete
DMEM media (cDMEM, 10% endotoxin-low FBS, 1%
P/S, 1% L-glutamine). Black, flat-bottomed, TC-treated,
96-well imaging plates (BD Falcon) were coated with
50 μl per well of poly-L-lysine (10 μg/ml, Sigma) for at
least 4 h at RT. Cells were plated on poly-L-lysine-
coated plates at a density of 5 × 105 cells/ml and 200 μl
volume per well and cultures were maintained at 37 °C,
5% CO2. Cells were cultured for 5 days in cDMEM
supplemented with human PDGFαα (10 ng/ml, Peprotech)
during which time an astrocyte monolayer formed. Cells
were cultured for a further 2 days in complete Neural
Medium (cNM, 2% MACS NeuroBrew-21, 1% P/S, 1%
L-glutamine) supplemented with PDGFαα (10 ng/ml,
Peprotech) for initial OPC expansion. At day 7 in cul-
ture, PDGFαα supplementation was stopped to allow
oligodendrocyte differentiation and cells were stimulated
as described in the appropriate figures for up to 5 days.
Pure OPC cultures
Pure OPC cultures were generated from P5–9 C57BL/6
mouse pups according to a protocol adapted from Rena
Hesse et al. [19]. Brains were dissected, cerebellum, ol-
factory bulbs and meninges were removed and tissue
was cut into small pieces. One to three brains per 10 cm
dish were papain enzyme-digested with 165 U papain
(Worthington) in 10 ml papain buffer (10% EBSS, 3.
6 mg/ml glucose, 26 mM NaHCO3, 1 mM MgSO4,
2 mM EGTA, 0.2 mg/ml L-cysteine, 40 mg/l DNase I)
for 5 min at 37 °C. Tissues were mechanically dissoci-
ated and step by step triturated in high inhibition buffer
(10% EBSS, 3.6 mg/ml glucose, 26 mM NaHCO3,
10 mg/ml ovomucoid trypsin inhibitor, 10 mg/ml BSA,
33.3 mg/ml DNase I) and then low inhibition buffer
(10% EBSS, 3.6 mg/ml glucose, 26 mM NaHCO3, 1.
3 mg/ml ovomucoid trypsin inhibitor, 1.3 mg/ml BSA,
17.4 mg/ml DNase I). The cell suspension was spun down
at 200 rcf for 10 min at RT and the visible cell swirl was
collected and resuspended in DPBS (Invitrogen) contain-
ing 0.2% BSA and 5 mg/l insulin. The remaining cell sus-
pension was again spun down at 300 rcf for 10 min at RT
and the visible cell swirl was again collected into the same
panning buffer-containing tube. Cells were then negatively
panned for 15 min at RT using Bandeira Griffonia Simpli-
cifolia Lectin 1 (BSL1) (10 cm dish precoated overnight at
4 °C with 0.2% BSL1 in DPBS, Vector Laboratories) to
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remove microglia. Afterwards pure OPCs were positively
selected by panning for PDGFRα (10 cm dish pre-coated
overnight at 4 °C with 0.3% goat anti-rat IgG (Invitrogen)
and then coated with 0.15% rat anti-PDGFRα (clone 38
APA5, Biolegend) for more than 4 h at RT). Pure OPCs
were scraped off after vigorous washing, plated on
poly-L-lysine-coated T75 flasks (10 μg/ml, 10 ml per
flask, Sigma) at 1–3 brains per flask in OPC medium
(DMEM with Glutamax, 0.04% B27 supplement,
100 ng/ml apo-transferrin, 100 ng/ml BSA, 62.5 ng/l
progesterone, 16 ng/ml putrescine, 40 ng/l sodium sel-
enite, 1% P/S, 60 mg/l N-acetyl-cysteine, 5 mg/l insulin,
0.1% Trace elements B, 1 ng/l biotin, 2 mg/l forskolin)
and maintained at 37 °C, 5% CO2. Medium was changed
every 3 days and cells were supplemented daily with hu-
man PDGFαα (10 ng/ml, Peprotech) and human NT3
(5 ng/ml, Peprotech). Black, flat-bottomed, TC-treated,
96-well imaging plates (BD Falcon) were coated with 50 μl
per well of poly-L-lysine (10 μg/ml, Sigma) overnight at
4 °C and on the next day with 50 μl per well of laminin
(10 μg/ml, Sigma) for at least one hour at 37 °C. After
7 days of proliferation, cells were transferred onto poly-L-
lysine- and laminin-coated plates at a density of 2 × 105
cells/ml and 200 μl volume per well and maintained for a
further 2 days under proliferating conditions. At day 9 in
culture, PDGFαα and NT3 supplementation were stopped
to allow oligodendrocyte differentiation and cells were
stimulated as described in the appropriate figures for up
to 3 days. Purity was assessed in random cultures at 3 to
5 days after setup and was usually over 93% as determined
by percentage Olig2+ cells of total DAPI+ cells.
LDH assay
To assay potential cell death in mixed neuron-glia cul-
tures, conditioned media were harvested and stored at −
20 °C prior to testing. Lactate dehydrogenase (LDH) ac-
tivity, as a surrogate indicator of cell death, was mea-
sured in conditioned media by a Cytotoxicity Detection
Kit (LDH) (Roche) as per manufacturer’s instructions. In
general, 100 μl of LDH reaction mixture (1:45 Catalyst:
Dye ratio) was added to 100 μl of mixed neuron-glia
conditioned media (n = 6 biological replicates per time-
point) in clear, flat-bottomed 96 well plates and incu-
bated in the dark for 30 min at RT. A background level
of LDH/substrate catalytic activity was determined by
assaying medium-only control, while a maximal cell
death control was measured by testing conditioned media
from mixed neuronal-glia cultures treated with 10%
DMSO. After incubation, samples were assayed using an
absorbance value of 491 nm, with a reference absorbance
of 600 nm, using an Epoch Microplate Spectrophotometer
(BioTek). Optical density (OD) values were calculated by
subtracting the 600 nm reference value from the 491 nm
value, followed by subtracting the medium-only control
value. To ascertain a surrogate readout for percentage of
total cell death OD values were divided by the maximum
cell death control (mixed neuron-glia treated with 10%
DMSO).
Immunofluorescence
Mixed neuron-glia cultures were washed once in PBS
prior to fixation, whereas pure OPC cultures were fixed
directly. Cell cultures were fixed in 4% paraformaldehyde
(pH 7.4) (Sigma) for 15–20 min at RT. After blocking in
10% normal goat serum (Vector Laboratories) with 0.1%
Triton-X-100 in PBS for 1 h, cells were incubated with
primary antibodies (anti-PDGFRα (clone APA5, 1:200,
Biolegend), anti-Olig2 (Millipore), anti-MBP (clone 12,
1:1000, Millipore), anti-MAP2 (clone AP-20, 1:200, Abcam),
anti-NF200 (clone RT97, 1:200, Millipore), anti-APC (clone
CC-1, 1:100, Abcam), anti-Ki67 (clone SolA15, 1:200,
eBioscience), anti-Iba1 (1:600, Wako), anti-Nkx2.2 (clone
74.5A5, 1:200, DSHB), anti-CD11b (clone M1/70, 1:200,
eBioscience), anti-GFAP (1:200, Dako), anti-CD45 (clone
104, 1:200, eBioscience), anti-PDGFRβ (clone 28E1, 1:100,
Cell signaling), anti-CD31 (clone H-3, 1:100, Santa Cruz),
anti-A2B5 (clone A2B5–105, 1:200, Millipore), anti-NG2
(clone 132.39, 1:200, Millipore), anti-Sox2 (clone 20G5, 1:
100, Abcam), anti-Oct4 (1:100, Abcam), anti-Sox1 (1:100,
Abcam), anti-O4 (clone 81, 1:200, Millipore)) in 2%
normal goat serum with 0.001% Triton-X-100 in PBS
overnight at 4 °C and in secondary antibodies (AF488
and AF594, 1:1000, Invitrogen) for 1 h at RT. Cells
were counterstained with DAPI for 5 min at RT. For
live/dead staining unfixed cells were stained using the
LIVE/DEAD© Viability/Cytotoxicity kit, for mammalian
cells (Invitrogen). Cells were stained with 0.2 μM calcein
and 2 μM Eth-D1 for 15 min at 37 °C and directly imaged.
Image analysis and data processing
Immunofluorescence was detected using an EVOS FL,
EVOS FL Auto or CellInsight CX4 microscope at 10× or
40× magnification and n = 3 to 6 wells per condition. Four
to 20 distinct field of view (FOV) images per well were an-
alyzed to generate mean values for each well. Counts of
oligodendrocyte lineage marker Olig2, OPC marker
PDGFRα, differentiated oligodendrocyte marker MBP,
proliferation marker Ki67, neuronal marker MAP2 and
microglial marker CD11b positive cells were performed
manually. For Fig. 6 counts of Olig2+Ki67+ cells were
determined with the cell count tool of IMARIS software.
Automated counting via IMARIS software (Bitplane) was
validated by manual blinded Olig2+ cell counts. MBP+
areas were determined using a fully automated custom
FIJI plugin [20], that was developed in-house (available
upon reasonable request from the corresponding author).
Briefly, MBP+ areas were determined from the number of
above-threshold pixels after applying a small median
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filter (radius = 1.5 pixels), followed by subtracting a
background image generated by the ‘subtract back-
ground’ command of ImageJ (sliding paraboloid option,
radius = 100 pixels). For each plate the threshold was
determined and the same threshold was applied to all
analyzed images within each experiment. While MBP+
area readouts are a more accurate measure of
oligodendrocyte myelin protein elaboration, the use of
MBP+ area readouts as a surrogate measure of Treg-
enhanced oligodendrocyte differentiation was validated by
manual blinded MBP+ cell counts.
Statistical analysis
Datasets were tested for statistical significance using un-
paired, two-tailed, Student’s t tests for parametric data
and Mann-Whitney tests for non-parametric data. Nor-
mality of datasets was determined using the KS normality
test. All statistical analysis and graphing were performed
using GraphPad Prism software.
Results
Characterization of mixed neuron-glia culture composition
To study the effects of Treg on OPCs in vitro, a model
containing a good proportion of OPCs was required. In
our hands, the murine mixed glial model, despite its
name, does not only contain populations of all main glial
cell types, but also a sizable population of MAP2+
neurons, thereby providing an in vitro model containing
all the main cell types commonly found in the CNS.
Therefore, we sought to carefully characterize the different
cell populations present in this mixed neuron-glia model.
To generate cultures that contained a sufficient number
of OPCs prior to treatment, murine mixed neuron-glia
cultures were expanded for 7 days in vitro (div) in the
presence of PDGFαα and stained for the oligodendroglial
lineage marker Olig2, together with a marker of OPCs
(platelet-derived growth factor receptor α (PDGFRα)),
proliferating cells (Ki67) and oligodendrocytes (myelin
basic protein (MBP)). Indeed, at 7 div the Olig2+
oligodendroglial lineage cell compartment predominantly
consisted of OPCs (approximately 80% PDGFRα+), with a
high proportion of proliferating OPCs (approximately 60%
Ki67+) and only a small percentage of differentiated MBP+
oligodendrocytes (< 5%) (see Fig. 1a, c). To further
characterize the composition of mixed neuron-glia cul-
tures at 7 div, cultures were additionally stained for
markers of astrocytes (Glial Fibrillary Acidic Protein
(GFAP)), microglia (CD11b) and neurons (Microtubule
Associated Protein 2 (MAP2)). Based on total DAPI+
cell, mixed glial cultures contained approximately 30%
of Olig2+ oligodendrocyte lineage cells, approximately
20% of neurons, approximately 5% of microglia and a
full layer of astrocytes, that was not readily quantifiable
via cell counting (see Fig. 1b, c). Based on the observed
astrocytic layer it is likely that astrocytes accounted for
about 45% of the remaining cells present in mixed
neuron-glia cultures. As mixed cultures were generated
from pups with ages ranging from 2 to 7 days, the indi-
vidual cell percentages did vary slightly between differ-
ent cultures (approximately +/− 5–10% depending on
the population), though the percentages reported were
the most representative. The existence of other poten-
tial cell populations within mixed neuron-glia cultures
was also further investigated. At 7 div Nestin+Sox1+
neural progenitor cells (NPCs) could not be detected
and there was only a very small population of CD31+
endothelial cells (see Additional file 1: Figure S1).
PDGFRβ+ pericytes were also undetectable at 7 div (see
Additional file 1: Figure S1). Additional markers used
to characterize these mixed neuron-glia cultures were
CD45+Iba1+ for microglia, NF200+ for neurons, A2B5+
and Nkx2.2+ for OPCs, O4+ for pre-oligodendrocytes
as well as APC+ and PLP+ for oligodendrocytes (see
Additional file 1: Figure S1).
After 7 div PDGFαα was withdrawn to allow natural
oligodendrocyte differentiation to occur for 5 days. At
12 div the oligodendroglial lineage cell compartment
had changed considerably. The percentage of PDGFRα+
OPCs decreased by approximately 30% (approximately
from 80% at 7 div to 50% at 12 div), whereas the percentage
of MBP+ oligodendrocytes proportionally increased by
approximately 10% (approximately from < 5% at 7 div to
10% at 12 div) while the percentage of Olig2+Ki67+
proliferating OPCs decreased by approximately 20%
(approximately from 60% at 7 div to 40% at 12 div) (see
Fig. 1a, c). Overall percentages in neuronal and glial
compartments remained largely unchanged during
oligodendrocyte differentiation (see Fig. 1b, c), although
Olig2 staining intensity was markedly dimmer at the
later timepoint, likely caused by a down-regulation of
the transcription factor Olig2 during oligodendrocyte
differentiation. Interestingly, the appearance of MAP2+
neurons changed from single cells with more ramified
morphology to largely bipolar shaped cell clusters that
were oriented in the same direction (see Fig. 1b, c).
Treg-conditioned media increase the proportion of
differentiated oligodendrocytes
We previously reported enhanced numbers of MBP+
oligodendrocytes in mixed glial cultures treated with
Treg-conditioned media [16]. In this study we focused
on proportional changes of not only oligodendrocytes,
but also OPCs and proliferating OPCs relative to the
total oligodendroglial population as a more in-depth and
alternative quantitative analysis. Additionally, potential
Treg effects on other mixed neuron-glia cell populations
were also investigated for the first time. In this study, in
agreement with our previous study which reported
Dittmer et al. Molecular Brain  (2018) 11:25 Page 5 of 13
findings based on total cell numbers and MBP+ area,
treatment with Treg-conditioned media significantly
increased the percentage of MBP+ oligodendrocytes
and reduced the percentage of PDGFRα+ OPCs by
approximately 20%, while there was no overall effect
on the percentage of proliferating OPCs (see Fig. 2a).
There was no effect of Treg-conditioned media on per-
centage of microglia in mixed glial cultures. The astrocytic
layer also did not seem to differ based on morphology.
Interestingly however, Treg-treated cultures showed a
a
c
b
Fig. 1 Oligodendroglial lineage cell composition in mixed neuron-glia cultures. Immunofluorescence analysis (a) of Olig2+ oligodendroglial cell population
for percentage of OPCs (PDGFRα+), oligodendrocytes (MBP+) and proliferating OPCs (Ki67+) and (b) of DAPI+ cells for percentage of oligodendroglial lineage
cells (Olig2+), neurons (MAP2+) and microglia (CD11b+) in mixed neuron-glia cultures at 7 or 12 div, n = 6 to 12 wells, representative of two independent
experiments. Data are from 4 different experiments depending on timepoint and marker. FOV = field of view= 1 mm2. (c) Representative images of mixed
neuron-glia cultures stained for oligodendrocytes (Olig2+MBP+), proliferating OPCs (Olig2+Ki67+), OPCs (Olig2+PDGFRα+), neurons (MAP2+), astrocytes (GFAP+),
microglia (CD11b+) and total cells (DAPI+) at 7 and 12 div
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significant reduction in the percentage of neurons (from
approximately 20 to 15%, see Fig. 2b). Morphologically,
Treg-treated cultures had fewer dense neuronal cell
clusters compared to control conditions and instead
more single neurons were detected.
Enhancing effect of Treg-conditioned media on
oligodendrocyte differentiation is not caused by
exogenous polarizing factors
Treg were generated from CD4+ T cells that were
polarized with IL-2, TGF-β and anti-IFN-γ. Harvested
Treg-conditioned media could still contain polarizing
factors even though most will have been consumed by T
cells during the 3 day activation period. Reports of the
effects of TGF-β on oligodendrocyte differentiation are
conflicting between different studies, showing an inhib-
ition of oligodendrocyte differentiation, inhibition of
OPC proliferation or enhancement of OPC proliferation
[21–23]. This reported difference could be due to the
different models utilized including primary rat or mouse
OPCs with different purification methods. However,
TGF-β treatment clearly has the potential to influence
oligodendrocyte differentiation. IL-2 has also been de-
scribed in the literature to enhance oligodendrocyte dif-
ferentiation [24]. Even anti-IFN-γ could potentially affect
oligodendrocyte differentiation, as OPCs express the
γ-chain of Fc receptors (FcRγ) and signaling through
FcRγ has been described to enhance oligodendrocyte
differentiation via Fyn kinase [25].
To confirm that the enhancement of oligodendrocyte
differentiation was indeed mediated by Treg and not an
artificial effect due to the use of Treg-polarizing factors,
the effects of the individual polarizing factors on MBP+
area were investigated. While MBP+ area represents a
more direct measure of oligodendrocyte myelin protein
elaboration, its use as a surrogate marker for Treg-
enhanced oligodendrocyte differentiation was confirmed
via MBP+ cell counting in Treg-enhanced oligodendro-
cyte differentiation [16]. Individually, none of the factors
used to polarize Treg affected oligodendrocyte differenti-
ation in mixed neuron-glia cultures at polarizing factor
concentrations equivalent to 5% Treg-polarized media
(see Additional file 1: Figure S2A,B). When a mix of
all polarizing cytokines was added to mixed neuron-
glial cultures there was a significant enhancement of
oligodendrocyte differentiation, although still to a
lesser extent than Treg-enhanced oligodendrocyte dif-
ferentiation (see Fig. 3a). It should be noted that the
concentrations of polarizing factors used in this ex-
periment, where equivalent to starting concentrations
used induce Treg polarization and amounts remaining
in conditioned media after 3 days of activation are
likely much lower. To exclude a potential direct effect
of Treg-polarizing factors on oligodendrocyte differenti-
ation, pure OPC cultures were also treated with a mixture
of IL-2, TGF-β and anti-IFN-γ at concentrations equivalent
to 5% Treg-polarized media treatment. Treg-enhancement
of oligodendrocyte differentiation in pure OPC cultures
was not mediated by exogenous Treg-polarizing factors,
but by products released by Treg (see Fig. 3b, c). Therefore,
while polarizing factors did not directly affect oligodendro-
cyte differentiation, there appears to be an indirect effect
on oligodendrocyte differentiation in mixed neuron-glia
cultures at maximum concentrations, and this effect is
significantly less than Treg-enhanced oligodendrocyte
differentiation.
Concentration response of Treg-enhanced
oligodendrocyte differentiation
Different cell types are cultured in varying media by dif-
ferent laboratories. Therefore, determining the differen-
tial effect of T cell media on OPC differentiation was
critical. Treg were activated multiple times in different
media (RPMI for 1st and BSM or X-VIVO™ 15 for subse-
quent activations) and Treg-conditioned media were
Fig. 2 Treg enhance OPC differentiation and reduce neuronal
percentages in mixed neuron-glia cultures. Mixed neuron-glia
cultures were treated with 5% Treg-conditioned media or matched
medium control for 5 days. Immunofluorescence analysis (a) of Olig2+
oligodendroglial cell population for percentage of OPCs (PDGFRα+),
oligodendrocytes (MBP+) and proliferating OPCs (Ki67+) and (b) of
DAPI+ cells for percentage of oligodendroglial lineage cells (Olig2+),
neurons (MAP2+) and microglia (CD11b+), n = 6 wells, mean +/− SEM,
Mann-Whitney test, (*) p < 0.05, (**) p < 0.01, representative of two
independent experiments. Data are from 5 different experiments
depending on timepoint and marker. FOV = field of view = 1 mm2
Dittmer et al. Molecular Brain  (2018) 11:25 Page 7 of 13
found to enhance oligodendrocyte differentiation irrespect-
ive of media type. However, the different media types also
enhanced oligodendrocyte differentiation to differing de-
grees. Media containing a higher percentage of serum en-
hanced oligodendrocyte differentiation more strongly, with
X-VIVO™ 15 medium (serum-free), RPMI medium (10%
FBS) and BSM (25% horse serum) inducing sequentially in-
creasing oligodendrocyte differentiation (see Fig. 4a). These
differences highlight the importance of using appropriate
controls, particularly in such neuroimmunological studies
in which different media support different cell types.
Treg can be activated multiple times in vitro. This can
be useful in producing a higher sample volume from the
same number of mice, thereby minimizing animal use.
Therefore, the effect of different cycles of T cell activa-
tions as well as different media types on Treg-enhanced
oligodendrocyte differentiation was investigated. Surpris-
ingly, Treg-conditioned media from both the 1st and 2nd,
but not the 3rd activation of Treg enhanced oligodendrocyte
differentiation (see Fig. 4b). Next, we determined the
minimum percentage of Treg-conditioned media necessary
to enhance oligodendrocyte differentiation consistently,
regardless of the type of conditioned media used. Inter-
estingly, non-linear concentration-dependent effects of
Treg-conditioned media were observed, especially when
using serum-containing media suggesting rate-limiting
steps in downstream signal transduction in oligodendro-
cyte differentiation. Overall, the lowest concentration of
Treg-conditioned media that elicited a significant en-
hancement of oligodendrocyte differentiation in all tested
samples was as low as 5%, which was used in all further
experiments (see Fig. 4c, d).
Timecourse of Treg-enhanced oligodendrocyte
differentiation
To ascertain the kinetics of oligodendrocyte differentiation
induced by Treg-conditioned media timecourse experi-
ments were performed. Treg-conditioned media consist-
ently enhanced oligodendrocyte differentiation robustly
after 5 days of treatment (see Fig. 5) with signs of
enhanced differentiation as early as 2 days after treatment
in one experiment. For consistency, further experiments
investigating the effects of Treg on oligodendrocyte
ba
c
Fig. 3 Exogenous Treg-polarizing factors do not directly affect OPC differentiation. (a) Mixed neuron-glia cultures were treated with Treg-polarizing
media (pol. media), a mixture of TGF-β (300 pg/ml), anti-IFN-γ (500 ng/ml) and IL-2 (500 pg/ml), compared to Treg-conditioned media and matched
medium control (X-VIVO™15) for 5 days (b) Pure OPC cultures were treated with a mixture of TGF-β (300 pg/ml), anti-IFN-γ (500 ng/ml) and IL-2
(500 pg/ml) compared to Treg-conditioned media and matched medium control (BSM) for 3 days. Immunofluorescence analysis of MBP+ area,
n = 6 wells, mean +/− SEM, unpaired t-test, (***) p < 0.001, representative of two independent experiments. FOV = field of view. (c) Representative
images of pure OPC cultures stained for oligodendrocytes (Olig2+MBP+) at 10× and 40× magnification at 12 div
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differentiation were all treated for 5 days. These experi-
ments highlight the inherent variability of murine
mixed neuron-glia cultures, which is likely caused by
the range of pup ages used (from 2 to 7 days), and
emphasizes the importance of kinetic studies such as
this to determine optimum settings for reliable
investigations.
Treg-conditioned media do not affect OPC proliferation
or survival
While treatment with Treg-conditioned media enhanced
the number of differentiated OPCs, this effect could also
be due to an underlying effect of Treg-conditioned
media on OPC proliferation or survival. Even though we
showed that OPC proliferation was unaffected by
a
c
b
d
Fig. 4 Concentration response of Treg-enhanced OPC differentiation. (a) Mixed neuron-glia cultures were treated with 5% of different media used
to activate T cells. (b) Mixed neuron-glia cultures were treated with 5% of Treg-conditioned media generated from the 1st, 2nd and 3rd activation
or matched medium control (RPMI for 1st and BSM for 2nd and 3rd activation) for 5 days. (c, d) Mixed neuron-glia cultures were treated with 2.5,
5, 10, 25 and 50% of Treg-conditioned media from (c) 1st and (d) 2nd Treg activation or matched medium control (c) RPMI, (d) BSM or X-VIVO™15 as
indicated) for 5 days. (a-d) Immunofluorescence analysis of MBP+ area, n= 6 wells and for (d) X-VIVO™15 n = 5 wells, mean +/− SEM, (a) Mann-Whitney
test, (b-c) unpaired t-test, (d) unpaired t-test or Mann-Whitney test as appropriate, (*) p < 0.05, (**) p< 0.01, (***) p< 0.001, (a-b) representative of two
independent experiments and (c-d) data are from a single experiment. FOV = field of view = 1 mm2
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treatment with Treg-conditioned media after 2 days of
treatment [16] this did not rule out an effect at different
time-points. Therefore, the effect of Treg-conditioned
media on OPC proliferation was investigated at multiple
timepoints. As PDGFαα was withdrawn on the day of
treatment, maximal OPC proliferation was expected to
be earlier than enhancement of oligodendrocyte differen-
tiation, which was observed at 5 days after treatment
(see Fig. 5). Indeed, OPC proliferation was highest before
PDGFαα-withdrawal and slowly decreased over time.
Treg-conditioned media did not affect OPC proliferation
at any time-point investigated up to 5 days after treat-
ment (see Fig. 6a).
Even though there was no effect of Treg-conditioned
media on OPC proliferation, an enhanced survival of
OPCs could still underlie the observed enhancement of
oligodendrocyte numbers. We previously showed no effect
of Treg-conditioned media on the number of EthD1+ cells
at one time-point (after 5 days of treatment) [16], there-
fore the effect of Treg-conditioned media on cell death
was investigated at a range of timepoints. There was no ef-
fect of Treg-conditioned media on cell survival in mixed
neuron-glia cultures up to 5 days after treatment as
measured by LDH release (see Fig. 6b).
Discussion
While many different groups utilize a variety of mixed glial
cultures to study glial cell populations, the actual compos-
ition, reproducibility and dynamics of these cultures are
rarely characterized. To investigate natural mediators in
the process of oligodendrocyte differentiation, we estab-
lished and characterized in detail a murine mixed neuron-
glia model. Mixed neuron-glia cultures generated from
P2–7 C57BL/6 mouse pups were shown to robustly consist
of a full astrocytic monolayer and high proportions of
oligodendroglial lineage cells, neurons and microglia, mak-
ing this an excellent reductionist model to investigate ef-
fects on oligodendrocyte differentiation in the presence of
all major CNS cell components. While oligodendrocyte
differentiation can be investigated efficiently in mixed
neuron-glia models, one limitation is that this model
does not inform about functional de- or remyelination.
We recently showed that Treg-secreted factors en-
hance oligodendrocyte differentiation, however this has
raised several fundamental questions pertaining to the
dynamics of the models used. Here we have addressed
key questions pertaining to the effects of different media
Fig. 5 Timecourse analysis of Treg-induced oligodendrocyte
differentiation. Mixed neuron-glia cultures were treated with 5%
Treg-conditioned media or matched medium control (BSM) for
up to 5 days. Immunofluorescence analysis of MBP+ area, n = 6
wells for Experiment 1 and n = 3 wells for Experiment 2, mean
+/− SEM, unpaired t-test and Mann-Whitney test as appropriate,
(**) p < 0.01. FOV = field of view = 1 mm2
Fig. 6 Treg do not affect OPC proliferation or survival in vitro.
Mixed neuron-glia cultures were treated with 5% Treg-conditioned
media or matched medium control (RPMI) for up to 5 days. (a)
Immunofluorescence analysis of Olig2+Ki67+ counts as a timecourse
after 1 to 5 days of treatment, n = 6 wells, mean +/− SEM, Mann-
Whitney test, representative of two independent experiments. FOV =
field of view= 1 mm2. (b) LDH assay of mixed neuron-glia conditioned
media after up to 5 days of treatment, n = 6 wells, mean +/− SEM,
Mann-Whitney test, representative of two independent experiments
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in which Treg were generated as well as the number of
times Treg were activated in vitro, the effect of the fac-
tors used to polarize Treg in vitro, the effect of different
concentrations of Treg-conditioned media as well the
dynamics of the Treg effect on mixed neuron-glia
cultures.
Treg-conditioned media enhanced the proportions of
mature oligodendrocytes. However, as Treg-polarizing
media contains exogenous factors known to affect oligo-
dendrocyte differentiation, we validated that these polar-
izing factors were not responsible for the observed
effects. The maximum concentration of polarizing fac-
tors (the amount added at the start of T cell activation)
was used to confirm the validity of the observed Treg ef-
fect. A mixture of all Treg polarizing factors caused an
enhancement of oligodendrocyte differentiation in mixed
neuron-glia cultures that was significantly lower than
Treg-conditioned media. In pure OPC cultures there
was no effect of a mixture of all Treg polarizing factors
on oligodendrocyte differentiation. These findings indicate
that all polarizing factors together at maximum concen-
trations are capable of inducing oligodendrocyte differen-
tiation through an indirect mechanism, but are not solely
responsible for the observed Treg-enhanced oligodendro-
cyte differentiation. Interestingly, while Treg-conditioned
media generated during the first and second activation en-
hanced oligodendrocyte differentiation to a similar degree,
this was not true for Treg activated for a third time. This
finding could give helpful insights into the factors secreted
by Treg that confer the oligodendrocyte differentiation
enhancing effect of Treg. While the effect of Treg did
not depend on the cell culture media type that Treg
were activated in, it is crucial to highlight that different
media affected baseline oligodendrocyte differentiation
to highly varying degrees, likely depending on respective
serum content. Additionally, there is an inherent variabil-
ity of Treg-enhanced oligodendrocyte differentiation in
mixed neuron-glia cultures due to the range of mouse pup
ages used to generate CNS cultures. This explains why
consistent enhancing effects of Treg-conditioned media
were observed but there was appreciable variation in fold
changes between experiments in this primary culture
system. This emphasizes the importance of ensuring that
appropriate matched controls are used in such studies.
While Treg-conditioned media significantly enhanced
the proportion of mature oligodendrocytes and reduced
the proportion of OPCs, there was also a surprising in-
hibitory effect of Treg-conditioned media on the propor-
tion of neurons in cultures. The cause for these reduced
numbers of neurons in mixed glial cultures in vitro re-
mains to be investigated. One possible explanation could
be that differentiating oligodendrocytes have high meta-
bolic demands due to production of vast amounts of new
membrane. As Treg-conditioned media enhances
oligodendrocyte differentiation there would be a higher
metabolic demand in these cultures and accordingly, less
nutrients available to other cells in the culture, potentially
causing the death of vulnerable neurons. Another possible
explanation could be that Treg-conditioned media exert a
toxic effect on neuronal cells. However, in functional
models of myelination such as an OPC-dorsal root gan-
glion (DRG) neuron co-culture, Treg-conditioned media
enhanced myelination [16]. Also, Treg-conditioned media
enhanced the proportion of myelinated or remyelinated
axons in brain slices ex vivo [16], suggesting that Treg do
not critically ablate neurons in models of myelination and
remyelination. Nevertheless, further investigation into the
effects of Treg on neurons in mixed cultures should be
performed.
We recently showed that Treg play a beneficial role in
myelin regeneration and enhance oligodendrocyte differ-
entiation [16]. Here we sought to clarify whether the en-
hancing effect of Treg on oligodendrocyte differentiation
may have been partially mediated by underlying effects
on either OPC proliferation or survival. We did not ob-
serve any effects of Treg-conditioned media on either
OPC proliferation or survival at any timepoint up to
5 days after treatment. While LDH release does not spe-
cifically inform about oligodendroglial-specific survival,
together with the results indicating that there was no ef-
fect of Treg on OPC proliferation or overall oligodendro-
glial cell population, these findings suggest a lack of effect
on OPC survival. It would be interesting to further in-
vestigate whether Treg-conditioned media might affect
OPC survival in challenging conditions such as hypoxia
or starvation. A pilot study was performed to investigate
the effect of neural medium supplement (Neurobrew-21)
withdrawal after 7 div. Surprisingly however, withdrawal
of this neural supplement reduced overall cell death and
enhanced oligodendrocyte differentiation in mixed glial
cultures (see Additional file 1: Figure S3), even though it
contains known enhancers of oligodendrocyte differenti-
ation such as Triiodothyronine / Thyroid hormone 3 (T3)
and other factors required for oligodendrocyte main-
tenance such as insulin, sodium selenite, putrescine and
D-galactose [26, 27]. Indeed, this pilot study questions
the usefulness of using Neurobrew-21 supplement in
mixed neuron-glia cultures but this certainly requires
further investigation.
We recently identified CCN3 as a Treg-secreted factor
capable of enhancing OPC differentiation [16]. However,
while the absence of Treg-secreted CCN3 impaired OPC
differentiation both in brain slices ex vivo as well as in
mixed neuron-glia cultures in vitro [16], Treg-derived
CCN3 did not affect oligodendrocyte differentiation in a
pure OPC model (data not shown). Therefore, Treg-derived
CCN3 did not appear to directly mediate oligodendrocyte
differentiation, suggesting that the Treg factor(s) exerting a
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direct effect on OPC differentiation (see Fig. 3) are indeed
different factor(s) and that CCN3 mediates its effect through
a different cell type or extracellular matrix component
present in mixed neuron-glia cultures. Microglia might in-
deed be prime candidates to facilitate the oligodendrocyte
differentiation-enhancing effect of CCN3, as CCN3 was
shown to polarize macrophages towards an M2 phenotype
[28] and M2 macrophages and microglia, in turn, enhance
oligodendrocyte differentiation [29]. Therefore there are
likely other Treg-secreted factors responsible for mediating
direct effects on oligodendrocyte differentiation, additional
to indirect effects mediated by Treg-derived CCN3, that
warrant further investigation in the future.
Murine mixed neuron-glia models are useful tools to
study effects on glial cell populations in a model of mini-
mum complexity with all the prevalent cell populations
of the central nervous system still present. These in vitro
models together with pure glial population models, such
as pure OPCs, provide an excellent tool for detailed in-
vestigation of basic biology and cellular mechanisms.
The use of well-characterized and robust in vitro models
across different laboratories is imperative for future identi-
fication of novel biological functions. This study provides
a robust characterization of a murine neuron-glia
model and describes the main cell populations composing
this culture at different time-points. Furthermore, we
described temporal dynamics of Treg-enhanced oligo-
dendrocyte differentiation, as well as effects of varied
activations, media, polarizing factors and concentrations.
These detailed investigations will support future cell-based
studies of oligodendrocyte differentiation as well as in-
vestigations in the influence of immune cells and other
mediators on this critical cellular process.
Additional file
Additional file 1: Figure S1. Mixed neuron-glia cultures contain a small
proportion of endothelial cells. Representative images of mixed neuron-glia
cultures stained for microglia (CD45+Iba1+), neurons (MAP2+NF200+),
astrocytes (GFAP+), OPCs (Olig2+ABA5+PDGFRα+Nkx2.2+), oligodendrocytes
(Olig2+O4+APC+PLP+MBP+, endothelial cell (CD31+), pericytes (PDGFRβ+)
and NPCs (Nestin+Sox1+). Figure S2. Single exogenous Treg-polarizing
factors do not affect OPC differentiation in mixed neuron-glia cultures.
Mixed neuron-glia cultures were treated with (A) IL-2 (500 pg/ml) or (B)
TGF-β (300 pg/ml) or anti-IFN-γ (500 ng/ml) compared to Treg-conditioned
media and matched medium control (BSM) for 5 days. Immunofluorescence
analysis of MBP+ area, n = 6 wells, mean +/− SEM, unpaired t-test,
representative of two independent experiments. FOV = field of view =
1 mm2. Figure S3. NeuroBrew-21 negatively affects OPC differentiation and
cell survival. Mixed neuron-glia cultures were treated with normal
differentiation medium (= + NeuroBrew-21) or with differentiation
medium without NeuroBrew-21 (= -NeuroBrew-21) for 5 days.
Immunofluorescence analysis of EthD-1+ cell counts and MBP+ area,
n = 6 wells, mean +/− SEM, unpaired t-test, representative of two
independent experiments. FOV = field of view = 1 mm2. (PPTX 5757 kb)
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